These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26708436)

  • 1. Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo.
    Geng Z; Luo X; Zhang Z; Li H; Tian J; Yu Z
    Int J Biol Macromol; 2016 Apr; 85():271-6. PubMed ID: 26708436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
    Camargo JA; Sapin A; Nouvel C; Daloz D; Leonard M; Bonneaux F; Six JL; Maincent P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):146-55. PubMed ID: 22397675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
    Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
    Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation.
    Lu M; Xiong D; Sun W; Yu T; Hu Z; Ding J; Cai Y; Yang S; Pan B
    Drug Deliv; 2017 Nov; 24(1):622-631. PubMed ID: 28282989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of an in situ forming gel system for sustained delivery of Florfenicol.
    Yu ZG; Geng ZX; Liu TF; Jiang F
    J Vet Pharmacol Ther; 2015 Jun; 38(3):271-7. PubMed ID: 25287575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The negative effects of the residues of ivermectin in cattle dung using a sustained-release bolus on Aphodius constans (Duft.) (Coleoptera: Aphodiidae).
    Errouissi F; Alvinerie M; Galtier P; Kerboeuf D; Lumaret JP
    Vet Res; 2001; 32(5):421-7. PubMed ID: 11592612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.
    Tian Y; Shen Y; Jv M
    Drug Deliv; 2016 Oct; 23(8):2726-2735. PubMed ID: 26289210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs.
    Eraslan G; Kanbur M; Liman BC; Cam Y; Karabacak M; Altinordulu S
    Food Chem Toxicol; 2010; 48(8-9):2181-5. PubMed ID: 20488222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of pharmacokinetic interaction between ivermectin and praziquantel after oral administration in healthy dogs.
    Ozdemir Z; Faki HE; Uney K; Tras B
    J Vet Pharmacol Ther; 2019 Sep; 42(5):497-504. PubMed ID: 31183888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced drug loading of in situ forming gels for oral mucositis pain control.
    Li T; Lalla RV; Burgess DJ
    Int J Pharm; 2021 Feb; 595():120225. PubMed ID: 33486019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.
    Yu Z; Guo F; Guo Y; Zhang Z; Wu F; Luo X
    PLoS One; 2017; 12(3):e0173949. PubMed ID: 28350799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study of pharmacokinetics of external, whole-body bathing application of ivermectin.
    Miyajima A; Komoda M; Akagi K; Yuzawa K; Yoshimasu T; Yamamoto Y; Hirota T
    J Dermatol; 2015 Jan; 42(1):87-9. PubMed ID: 25492083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems.
    Liu H; Venkatraman SS
    J Pharm Sci; 2012 May; 101(5):1783-93. PubMed ID: 22318766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
    Gokbulut C; Biligili A; Kart A; Turgut C
    Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of extended-release ivermectin microspheres after oral administration to healthy pigs.
    Xu Y; Zhang S; Qiu Y; Yu Y; Zhang Y; Huang X
    J Vet Pharmacol Ther; 2020 Sep; 43(5):485-490. PubMed ID: 32304335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tablets based on compressed zein microspheres for sustained oral administration: design, pharmacokinetics, and clinical study.
    Gong SJ; Sun SX; Sun QS; Wang JY; Liu XM; Liu GY
    J Biomater Appl; 2011 Aug; 26(2):195-208. PubMed ID: 20418265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses.
    Gokbulut C; Cirak VY; Senlik B; Aksit D; Durmaz M; McKellar QA
    Vet Parasitol; 2010 May; 170(1-2):120-6. PubMed ID: 20181429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.